Hilltop National Bank Catalyst Pharmaceuticals, Inc. Transaction History
Hilltop National Bank
- $311 Billion
- Q2 2024
A detailed history of Hilltop National Bank transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Hilltop National Bank holds 900 shares of CPRX stock, worth $15,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
900
Previous 900
-0.0%
Holding current value
$15,831
Previous $14.3 Million
2.82%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
278Shares Held
95.6MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$312 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$161 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$143 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$140 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.74MShares$48.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.81B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...